Market revenue in 2023 | USD 42.8 million |
Market revenue in 2030 | USD 69.4 million |
Growth rate | 7.2% (CAGR from 2023 to 2030) |
Largest segment | Infectious diseases |
Fastest growing segment | Oncology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, Prenatal Testing, Endocrinology, Other Applications, Hematology, Infectious Diseases |
Key market players worldwide | Roche, Abbott Laboratories, Qiagen NV, Bayer AG, Nova Biomedical, Danaher Corp, Nipro Corp, Bio-Rad Laboratories Inc, Agilent Technologies Inc, BioMerieux SA, OraSure Technologies Inc, Abaxis |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care molecular diagnostics market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 93.46% in 2023. Horizon Databook has segmented the South Korea point-of-care molecular diagnostics market based on oncology, prenatal testing, endocrinology, other applications, hematology, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea is witnessing significant advancements in terms of sensors incorporated in minimally invasive as well as noninvasive glucose monitoring systems. For instance, in August 2022, DxGen Corp entered into a partnership agreement with Precision Diabetes, Inc. to launch a fully automatic POC analyzer, Epithod AutoDx, which measures a comprehensive profile of diabetes tests.
In addition, the Ulsan National Institute of Korea (UNIST) is engaged in the development of soft lenses for smart contact lenses, including glucose detection. Moreover, the Electronics and Telecommunications Research Institute in Korea (ETRI) is focusing on the development of a fingertip glucose detection system via photoacoustic spectroscopy technology. Thus, continuous developments in the country have boosted the demand for POC diagnostic tests.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea point-of-care molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into South Korea point-of-care molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account